Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Fibromyalgia (Fibromyalgia Syndrome) - Overview
Fibromyalgia (Fibromyalgia Syndrome) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Fibromyalgia (Fibromyalgia Syndrome) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Fibromyalgia (Fibromyalgia Syndrome) - Companies Involved in Therapeutics Development
Aptinyx Inc
Astellas Pharma Inc
Grunenthal GmbH
H. Lundbeck AS
Innovative Med Concepts LLC
Intec Pharma Ltd
Jiangsu Hengrui Medicine Co Ltd
Luye Pharma Group Ltd
Tetra Bio-Pharma Inc
Teva Pharmaceutical Industries Ltd
Tonix Pharmaceuticals Holding Corp
Vitality Biopharma Inc
Fibromyalgia (Fibromyalgia Syndrome) - Drug Profiles
(celecoxib + famciclovir) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ABX-1626 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ASP-0819 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
canbidiol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
drobinol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
faxeladol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fremanezumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LY-03012 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MS-11 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ltrexone hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NP-013 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NYX-2925 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
palmidrol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptide to Block Voltage-Dependent N-Type Calcium Channel for Central Nervous System - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PPP-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pregabalin SR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule 1 to Agonize CB1 and CB2 for Chronic Pain and Fibromyalgia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Agonize CB1 and CB2 for Fibromyalgia and Chronic Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TNX-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Type 1 Diabetes and Fibromyalgia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VB-210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Fibromyalgia (Fibromyalgia Syndrome) - Dormant Projects
Fibromyalgia (Fibromyalgia Syndrome) - Discontinued Products
Fibromyalgia (Fibromyalgia Syndrome) - Product Development Milestones
Featured News & Press Releases
Oct 28, 2019: Aptinyx announces results of phase 2 fibromyalgia study of NYX-2925 have been selected for late-breaking presentation at the American College of Rheumatology Annual Meeting
Oct 03, 2019: Tonix Pharmaceuticals announces completion of long-term exposure studies in participants with PTSD to evaluate the Tolerability of TNX-102 SL 5.6 mg
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Fibromyalgia (Fibromyalgia Syndrome), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019

 

List of Tables


Number of Products under Development for Fibromyalgia (Fibromyalgia Syndrome), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Aptinyx Inc, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Astellas Pharma Inc, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Grunenthal GmbH, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by H. Lundbeck AS, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Innovative Med Concepts LLC, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Intec Pharma Ltd, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Luye Pharma Group Ltd, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Tetra Bio-Pharma Inc, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Teva Pharmaceutical Industries Ltd, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Tonix Pharmaceuticals Holding Corp, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Pipeline by Vitality Biopharma Inc, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Dormant Projects, H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Dormant Projects, H2 2019 (Contd..1), H2 2019
Fibromyalgia (Fibromyalgia Syndrome) - Discontinued Products, H2 2019